Herbal drug formulations represent complex multi-component therapeutic systems whose efficacy often exceeds predictions based on individual constituents, suggesting synergistic interactions among phytochemicals. This article examines the mechanistic basis, experimental validation, and translational potential of phytochemical synergy in botanical therapeutics. Synergy arises through pharmacodynamic mechanisms including multi-target modulation, pathway-level interactions, and network effects, as well as pharmacokinetic enhancements involving bioavailability optimization, metabolic modulation, and transporter interference. Quantification of synergy employs mathematical frameworks such as the Combination Index, Bliss independence, and Loewe additivity models, integrated with dose-response experimental designs. Modern analytical approaches including metabolomics profiling, network pharmacology, and systems biology enable identification of active chemical clusters and mechanistic pathway validation. Applications span anti-inflammatory, antimicrobial, metabolic, and oncology supportive care, with documented resistance-modifying effects. Critical challenges include chemical variability, standardization requirements, herb-drug interaction risks, and regulatory barriers. Advanced formulation science strategies, AI-guided mixture optimization, and integration with precision medicine platforms offer pathways toward reproducible, evidence-based herbal therapeutics. Future development requires standardized synergy-testing protocols, robust quality control systems, and mechanistic validation to translate traditional multi-component formulations into clinically validated pharmaceutical products.